| Coralys Andrea Melendez Tur, PHARMD | |
|
Villa Caparra 178 Carr2, Guaynabo, PR 00966 | |
| (787) 706-3600 | |
| Not Available |
| Full Name | Coralys Andrea Melendez Tur |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | Villa Caparra 178 Carr2, Guaynabo, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700488640 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 6801 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Coralys Andrea Melendez Tur, PHARMD Urb. Pradera Almira, Aj6 Calle 6, Toa Baja, PR 00949 Ph: (787) 420-1661 | Coralys Andrea Melendez Tur, PHARMD Villa Caparra 178 Carr2, Guaynabo, PR 00966 Ph: (787) 706-3600 |
News Archive
Scientists have identified a gene that appears to play a significant role in raising a person's risk of having more severe subtypes of autism that co-occur with other genetic diseases, such as the chromosomal disorder 22q11.2 deletion syndrome.
Mylan Inc. has confirmed that the company and its subsidiary, Mylan Pharmaceuticals Inc., have been sued by Cephalon Inc., Eurand Inc. and Anesta AG in connection with the filing of an Abbreviated New Drug Application (ANDA) for Cyclobenzaprine Hydrochloride (HCl) Extended-release (ER) Capsules, 15 mg and 30 mg, the generic version of AMRIX Capsules.
The risk for heart-related death is increasing in young adults ages 35 to 54, and the numbers are even more alarming for younger women. It is the number-one cause of death for both men and women in the United States, yet every year since 1984 more women have died of cardiovascular health problems than men, according to the American Heart Association.
Pacific Islanders are persons who trace their roots to the native peoples of Hawaii, Guam, Samoa, or other Pacific Islands. Although they make up the third fastest growing racial group in the U.S., their mental health needs and attitudes regarding mental illness are poorly understood.
Gentium S.p.A. has announced top-line results from a historically controlled, multicenter, open label, Phase III trial designed to evaluate the safety and efficacy of 25 mg/kg/day of Defibrotide for the treatment of severe veno-occlusive disease (sVOD) in hematopoietic stem cell transplant (SCT) patients.
› Verified 4 days ago
Aurea E Santiago, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Cond Atrium Park # A303, Guaynabo, PR 00969 Phone: 787-529-1821 Fax: 787-287-0558 | |
Camille N Lorenzo Medrano, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 580 Marginal Buchanan, Guaynabo, PR 00966 Phone: 787-792-3725 | |
Miss Elba Maria Garcia - Quintana, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: B7 Calle Tabonuco Ste 301, Guaynabo, PR 00968 Phone: 787-705-6622 | |
Gilmary Betancourt Marrero, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2505 Carr 841, Guaynabo, PR 00969 Phone: 787-287-0528 | |
Monica Z Andino, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 139 Carr 2, Bo Juan Domingo Ste1, Guaynabo, PR 00966 Phone: 787-782-0728 Fax: 787-749-0875 | |
Maria Rosado, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 47 Ave Esmeralda, Urb Munoz Rivera, Guaynabo, PR 00969 Phone: 787-720-7439 Fax: 787-790-3925 | |
Mrs. Carmen Pilar Bou, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: B12 Calle B, Villa De Tintillo, Guaynabo, PR 00966 Phone: 787-783-4285 Fax: 787-793-4159 |